{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T01:15:47Z","timestamp":1775697347428,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetes Ther"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s13300-025-01756-1","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:06:25Z","timestamp":1748995585000},"page":"1533-1555","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Continuous Glucose Monitoring Among People with and without Diabetes Mellitus and Sleep Apnoea"],"prefix":"10.1007","volume":"16","author":[{"given":"Evanthia","family":"Gouveri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fotios","family":"Drakopanagiotakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodoros","family":"Panou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Papazoglou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paschalis","family":"Steiropoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7320-785X","authenticated-orcid":false,"given":"Nikolaos","family":"Papanas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"issue":"5","key":"1756_CR1","doi-asserted-by":"publisher","first-page":"954","DOI":"10.2337\/dc18-2004","volume":"42","author":"A Subramanian","year":"2019","unstructured":"Subramanian A, Adderley NJ, Tracy A, et al. Risk of incident obstructive sleep apnea among patients with type 2 diabetes. Diabetes Care. 2019;42(5):954\u201363.","journal-title":"Diabetes Care"},{"issue":"4","key":"1756_CR2","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1007\/s11325-021-02556-0","volume":"26","author":"X Zhao","year":"2022","unstructured":"Zhao X, Zhang W, Xin S, Yu X, Zhang X. Effect of CPAP on blood glucose fluctuation in patients with type 2 diabetes mellitus and obstructive sleep apnea. Sleep Breath. 2022;26(4):1875\u201383.","journal-title":"Sleep Breath"},{"issue":"1","key":"1756_CR3","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/j.diabres.2010.09.029","volume":"91","author":"S Fendri","year":"2011","unstructured":"Fendri S, Rose D, Myambu S, Jeanne S, Lalau JD. Nocturnal hyperglycaemia in type 2 diabetes with sleep apnoea syndrome. Diabetes Res Clin Pract. 2011;91(1):e21-23.","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"1756_CR4","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.chest.2017.05.009","volume":"152","author":"S Reutrakul","year":"2017","unstructured":"Reutrakul S, Mokhlesi B. Obstructive sleep apnea and diabetes: a state of the art review. Chest. 2017;152(5):1070\u201386.","journal-title":"Chest"},{"issue":"14","key":"1756_CR5","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1001\/jama.295.14.1681","volume":"295","author":"L Monnier","year":"2006","unstructured":"Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, Colette C. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006;295(14):1681\u20137.","journal-title":"JAMA"},{"issue":"1","key":"1756_CR6","doi-asserted-by":"publisher","first-page":"17877","DOI":"10.1038\/s41598-020-74908-x","volume":"10","author":"JI Byun","year":"2020","unstructured":"Byun JI, Cha KS, Jun JE, et al. Dynamic changes in nocturnal blood glucose levels are associated with sleep-related features in patients with obstructive sleep apnea. Sci Rep. 2020;10(1):17877.","journal-title":"Sci Rep"},{"issue":"1","key":"1756_CR7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1055\/a-2414-5487","volume":"133","author":"T Panou","year":"2025","unstructured":"Panou T, Roukas K, Chadia K, Nena E, Gouveri E, Papanas N, Steiropoulos P. Obstructive sleep apnoea and type 1 diabetes mellitus: a neglected relationship? Exp Clin Endocrinol Diabetes. 2025;133(1):40\u201350.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"2","key":"1756_CR8","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s11325-021-02442-9","volume":"26","author":"K Saito","year":"2022","unstructured":"Saito K, Okada Y, Keiichi Torimoto K, Takamatsu Y, Tanaka Y. Blood glucose dynamics during sleep in patients with obstructive sleep apnea and normal glucose tolerance: effects of CPAP therapy. Sleep Breath. 2022;26(2):771\u201381.","journal-title":"Sleep Breath"},{"issue":"8","key":"1756_CR9","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1111\/j.1464-5491.2010.02967.x","volume":"27","author":"A Ceriello","year":"2010","unstructured":"Ceriello A, Ihnat MA. \u201cGlycaemic variability\u201d: a new therapeutic challenge in diabetes and the critical care setting. Diabet Med. 2010;27(8):862\u20137.","journal-title":"Diabet Med"},{"issue":"16","key":"1756_CR10","doi-asserted-by":"publisher","first-page":"8393","DOI":"10.3390\/ijms22168393","volume":"22","author":"V Alfieri","year":"2021","unstructured":"Alfieri V, Myasoedova VA, Vinci MC, et al. The role of glycaemic variability in cardiovascular disorders. Int J Mol Sci. 2021;22(16):8393.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1756_CR11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jjcc.2021.08.009","volume":"79","author":"K Tateishi","year":"2022","unstructured":"Tateishi K, Saito Y, Kitahara H, Kobayashi Y. Impact of glycaemic variability on coronary and peripheral endothelial dysfunction in patients with coronary artery disease. J Cardiol. 2022;79(1):65\u201370.","journal-title":"J Cardiol"},{"key":"1756_CR12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40842-020-00098-0","volume":"6","author":"SS Khaire","year":"2020","unstructured":"Khaire SS, Gada JV, Utpat KV, Shah N, Varthakavi PK, Bhagwat NM. A study of glycemic variability in patients with type 2 diabetes mellitus with obstructive sleep apnea syndrome using a continuous glucose monitoring system. Clin Diabetes Endocrinol. 2020;6:10.","journal-title":"Clin Diabetes Endocrinol"},{"issue":"1","key":"1756_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.4239\/wjd.v2.i1.16","volume":"2","author":"P Steiropoulos","year":"2011","unstructured":"Steiropoulos P, Papanas N. Continuous positive airway pressure to improve insulin resistance and glucose homeostasis in sleep apnea. World J Diabetes. 2011;2(1):16\u20138.","journal-title":"World J Diabetes"},{"issue":"5","key":"1756_CR14","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.13331","volume":"30","author":"MS Tasbakan","year":"2021","unstructured":"Tasbakan MS, Grote L, Hedner J, et al. Positive airway pressure (PAP) treatment reduces glycated hemoglobin (HbA1c) levels in obstructive sleep apnea patients with concomitant weight loss: Longitudinal data from the ESADA. J Sleep Res. 2021;30(5): e13331.","journal-title":"J Sleep Res"},{"key":"1756_CR15","doi-asserted-by":"publisher","DOI":"10.1177\/15347346221113992","author":"E Gouveri","year":"2022","unstructured":"Gouveri E, Steiropoulos P, Papanas N. Does Obstructive sleep apnoea syndrome influence the development and treatment of diabetic foot? A brief narrative review. Int J Low Extrem Wounds. 2022. https:\/\/doi.org\/10.1177\/15347346221113992.","journal-title":"Int J Low Extrem Wounds"},{"key":"1756_CR16","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.2147\/IJGM.S280837","volume":"13","author":"CY Wei","year":"2020","unstructured":"Wei CY, He ZM, Yan H, Li J, An P, Zhao L, Ji LN, Gao ZC, Dong XS, Han F. Treatment effects of short-term continuous positive airway pressure on blood glucose control in type 2 diabetic patients with obstructive sleep apnea syndrome. Int J Gen Med. 2020;13:1567\u201373.","journal-title":"Int J Gen Med"},{"issue":"1","key":"1756_CR17","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.sleep.2010.04.017","volume":"12","author":"P Bialasiewicz","year":"2011","unstructured":"Bialasiewicz P, Czupryniak L, Pawlowski M, Nowak D. Sleep disordered breathing in REM sleep reverses the downward trend in glucose concentration. Sleep Med. 2011;12(1):76\u201382.","journal-title":"Sleep Med"},{"issue":"9","key":"1756_CR18","first-page":"465","volume":"15","author":"A Elizur","year":"2013","unstructured":"Elizur A, Maliar A, Shpirer I, Buchs AE, Shiloah E, Rapoport MJ. Decreased nocturnal glucose variability in non-diabetic patients with sleep apnea: a pilot study. Isr Med Assoc J. 2013;15(9):465\u20139.","journal-title":"Isr Med Assoc J"},{"key":"1756_CR19","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.diabres.2017.08.010","volume":"134","author":"CS Peng","year":"2017","unstructured":"Peng CS, Cao YA, Tian YH, Zhang WL, Xia J, Yang L. Features of continuous glycemic profile and glycemic variability in patients with obstructive sleep apnea syndrome. Diabetes Res Clin Pract. 2017;134:106\u201312.","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"1756_CR20","doi-asserted-by":"publisher","first-page":"144","DOI":"10.4093\/dmj.2018.0256","volume":"43","author":"SO Song","year":"2019","unstructured":"Song SO, He K, Narla RR, et al. Metabolic consequences of obstructive sleep apnea especially pertaining to diabetes mellitus and insulin sensitivity. Diabetes Metab J. 2019;43(2):144\u201355.","journal-title":"Diabetes Metab J"},{"key":"1756_CR21","doi-asserted-by":"crossref","unstructured":"Figorilli M, Velluzzi F, Redolfi S. Obesity and sleep disorders: a bidirectional relationship. Nutr Metab Cardiovasc Dis. 2025;35(6):104014.","DOI":"10.1016\/j.numecd.2025.104014"},{"issue":"3","key":"1756_CR22","doi-asserted-by":"publisher","first-page":"e1267","DOI":"10.1210\/clinem\/dgad572","volume":"109","author":"EJ Meyer","year":"2024","unstructured":"Meyer EJ, Wittert GA. Approach the patient with obstructive sleep apnea and obesity. J Clin Endocrinol Metab. 2024;109(3):e1267\u201379.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1756_CR23","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.amjms.2015.12.002","volume":"351","author":"P Hui","year":"2016","unstructured":"Hui P, Zhao L, Xie Y, et al. Nocturnal hypoxemia causes hyperglycemia in patients with obstructive sleep apnea and type 2 diabetes mellitus. Am J Med Sci. 2016;351(2):160\u20138.","journal-title":"Am J Med Sci"},{"issue":"1","key":"1756_CR24","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1507\/endocrj.EJ17-0356","volume":"65","author":"H Kurosawa","year":"2018","unstructured":"Kurosawa H, Saisho Y, Fukunaga K, et al. Association between severity of obstructive sleep apnea and glycated hemoglobin level in Japanese individuals with and without diabetes. Endocr J. 2018;65(1):121\u20137.","journal-title":"Endocr J"},{"key":"1756_CR25","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.sleep.2022.04.007","volume":"95","author":"RN Aurora","year":"2022","unstructured":"Aurora RN, Gaynanova I, Patel P, Punjabi NM. Glucose profiles in obstructive sleep apnea and type 2 diabetes mellitus. Sleep Med. 2022;95:105\u201311.","journal-title":"Sleep Med"},{"issue":"4","key":"1756_CR26","doi-asserted-by":"publisher","first-page":"3873","DOI":"10.1111\/biom.13878","volume":"79","author":"R Sergazinov","year":"2023","unstructured":"Sergazinov R, Leroux A, Cui E, et al. A case study of glucose levels during sleep using multilevel fast function on scalar regression inference. Biometrics. 2023;79(4):3873\u201382.","journal-title":"Biometrics"},{"issue":"1","key":"1756_CR27","doi-asserted-by":"publisher","first-page":"81","DOI":"10.5665\/sleep.1590","volume":"35","author":"MM Perfect","year":"2012","unstructured":"Perfect MM, Patel PG, Scott RE, et al. Sleep, glucose, and daytime functioning in youth with type 1 diabetes. Sleep. 2012;35(1):81\u20138.","journal-title":"Sleep"},{"issue":"6","key":"1756_CR28","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.jdiacomp.2018.03.010","volume":"32","author":"M Kostkova","year":"2018","unstructured":"Kostkova M, Durdik P, Ciljakova M, et al. Short-term metabolic control and sleep in children and adolescents with type 1 diabetes mellitus. J Diabetes Complic. 2018;32(6):580\u20135.","journal-title":"J Diabetes Complic"},{"key":"1756_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2022.109786","volume":"185","author":"D Basille","year":"2022","unstructured":"Basille D, Timmerman M, Basille-Fantinato A, Al-Salameh A, Fendri S, Lalau JD. Screening for sleep-disordered breathing in people with type 1 diabetes by combining polysomnography with glucose variability assessment. Diabetes Res Clin Pract. 2022;185: 109786.","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"1756_CR30","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1001\/archinte.165.4.447","volume":"165","author":"AR Babu","year":"2005","unstructured":"Babu AR, Herdegen J, Fogelfeld L, Shott S, Mazzone T. Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch Intern Med. 2005;165(4):447\u201352.","journal-title":"Arch Intern Med"},{"issue":"5","key":"1756_CR31","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/sleep\/28.5.601","volume":"28","author":"L Czupryniak","year":"2005","unstructured":"Czupryniak L, Loba J, Pawlowski M, Nowak D, Bialasiewicz P. Treatment with continuous positive airway pressure may affect blood glucose levels in nondiabetic patients with obstructive sleep apnea syndrome. Sleep. 2005;28(5):601\u20133.","journal-title":"Sleep"},{"issue":"1","key":"1756_CR32","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1016\/j.diabres.2008.03.012","volume":"81","author":"M Pallayova","year":"2008","unstructured":"Pallayova M, Donic V, Tomori Z. Beneficial effects of severe sleep apnea therapy on nocturnal glucose control in persons with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2008;81(1):e8-11.","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"1756_CR33","doi-asserted-by":"publisher","first-page":"538","DOI":"10.5664\/jcsm.27347","volume":"4","author":"A Dawson","year":"2008","unstructured":"Dawson A, Abel SL, Loving RT, et al. CPAP therapy of obstructive sleep apnea in type 2 diabetics improves glycemic control during sleep. J Clin Sleep Med. 2008;4(6):538\u201342.","journal-title":"J Clin Sleep Med"},{"issue":"17","key":"1756_CR34","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.4103\/0366-6999.163382","volume":"128","author":"LX Guo","year":"2015","unstructured":"Guo LX, Zhao X, Pan Q, et al. Effect of continuous positive airway pressure therapy on glycemic excursions and insulin sensitivity in patients with obstructive sleep apnea-hypopnea syndrome and type 2 diabetes. Chin Med J (Engl). 2015;128(17):2301\u20136.","journal-title":"Chin Med J (Engl)"},{"issue":"12","key":"1756_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0188689","volume":"12","author":"K Nakata","year":"2017","unstructured":"Nakata K, Miki T, Tanno M, et al. Distinct impacts of sleep-disordered breathing on glycemic variability in patients with and without diabetes mellitus. PLoS\u00a0One. 2017;12(12): e0188689.","journal-title":"PLoS\u00a0One"},{"issue":"1","key":"1756_CR36","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s11325-016-1388-y","volume":"21","author":"EM Morariu","year":"2017","unstructured":"Morariu EM, Chasens ER, Strollo PJ Jr, Korytkowski M. Effect of continuous positive airway pressure (CPAP) on glycemic control and variability in type 2 diabetes. Sleep Breath. 2017;21(1):145\u20137.","journal-title":"Sleep Breath"},{"issue":"2","key":"1756_CR37","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/jdi.12682","volume":"9","author":"P Dong","year":"2018","unstructured":"Dong P, Xu J, Wang J, Zhang C. Application of 3C insulin pump system in combination with non-invasive ventilation in the treatment of a patient with type 2 diabetes and obstructive sleep apnea syndrome. J Diabetes Investig. 2018;9(2):442\u20134.","journal-title":"J Diabetes Investig"},{"issue":"2","key":"1756_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/edm2.148","volume":"4","author":"AM Bangh\u00f8j","year":"2020","unstructured":"Bangh\u00f8j AM, Krogager C, Kristensen PL, et al. Effect of 12-week continuous positive airway pressure therapy on glucose levels assessed by continuous glucose monitoring in people with type 2 diabetes and obstructive sleep apnoea; a randomized controlled trial. Endocrinol Diabetes Metab. 2020;4(2): e00148.","journal-title":"Endocrinol Diabetes Metab"},{"issue":"4","key":"1756_CR39","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.chest.2023.04.017","volume":"164","author":"RN Aurora","year":"2023","unstructured":"Aurora RN, Rooney MR, Wang D, Selvin E, Punjabi NM. Effects of positive airway pressure therapy on glycemic variability in patients with type 2 diabetes and OSA: a randomized controlled trial. Chest. 2023;164(4):1057\u201367.","journal-title":"Chest"},{"issue":"3","key":"1756_CR40","doi-asserted-by":"publisher","first-page":"522","DOI":"10.3390\/neurolint16030039","volume":"16","author":"A Maniaci","year":"2024","unstructured":"Maniaci A, La Via L, Pecorino B, et al. Obstructive sleep apnea in pregnancy: a comprehensive review of maternal and fetal implications. Neurol Int. 2024;16(3):522\u201332.","journal-title":"Neurol Int"},{"issue":"1","key":"1756_CR41","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s43032-022-00904-3","volume":"30","author":"X Tong","year":"2023","unstructured":"Tong X, Yang L, Jiang C, et al. A review of the associations between obstructive sleep apnea and gestational diabetes mellitus and possible mechanisms of disease. Reprod Sci. 2023;30(1):81\u201392.","journal-title":"Reprod Sci"},{"issue":"4","key":"1756_CR42","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.chest.2017.10.011","volume":"153","author":"S Pamidi","year":"2018","unstructured":"Pamidi S, Kimoff RJ. Maternal Sleep-disordered breathing. Chest. 2018;153(4):1052\u201366.","journal-title":"Chest"},{"issue":"10","key":"1756_CR43","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.2337\/dc13-0778","volume":"36","author":"MA Luque-Fernandez","year":"2013","unstructured":"Luque-Fernandez MA, Bain PA, Gelaye B, Redline S, Williams MA. Sleep-disordered breathing and gestational diabetes mellitus: a meta-analysis of 9795 participants enrolled in epidemiological observational studies. Diabetes Care. 2013;36(10):3353\u201360.","journal-title":"Diabetes Care"},{"issue":"1","key":"1756_CR44","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.chest.2020.07.014","volume":"159","author":"R Newbold","year":"2021","unstructured":"Newbold R, Benedetti A, Kimoff RJ, et al. Maternal sleep-disordered breathing in pregnancy and increased nocturnal glucose levels in women with gestational diabetes mellitus. Chest. 2021;159(1):356\u201365.","journal-title":"Chest"},{"issue":"5","key":"1756_CR45","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1164\/rccm.202401-0099LE","volume":"210","author":"J Smocot","year":"2024","unstructured":"Smocot J, Benedetti A, Newbold R, et al. Impact of continuous positive airway pressure on glucose profiles in gestational diabetes: a pilot randomized controlled trial. Am J Respir Crit Care Med. 2024;210(5):677\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"1756_CR46","first-page":"7489795","volume":"2020","author":"E Papachristoforou","year":"2020","unstructured":"Papachristoforou E, Lambadiari V, Maratou E, Makrilakis K. Association of glycemic indices (hyperglycemia, glucose variability, and hypoglycemia) with oxidative stress and diabetic complications. Diabetes Res. 2020;2020:7489795.","journal-title":"Diabetes Res"},{"issue":"4","key":"1756_CR47","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s10286-015-0301-2","volume":"25","author":"JK Limberg","year":"2015","unstructured":"Limberg JK, Dube S, Kuijpers M, et al. Effect of hypoxia on heart rate variability and baroreflex sensitivity during hypoglycemia in type 1 diabetes mellitus. Clin Auton Res. 2015;25(4):243\u201350.","journal-title":"Clin Auton Res"},{"issue":"4","key":"1756_CR48","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/j.1464-5491.2009.02684.x","volume":"26","author":"P Bialasiewicz","year":"2009","unstructured":"Bialasiewicz P, Pawlowski M, Nowak D, Loba J, Czupryniak L. Decreasing concentration of interstitial glucose in REM sleep in subjects with normal glucose tolerance. Diabet Med. 2009;26(4):339\u201344.","journal-title":"Diabet Med"},{"issue":"5","key":"1756_CR49","doi-asserted-by":"publisher","first-page":"810","DOI":"10.2337\/dc18-2212","volume":"42","author":"GR Law","year":"2019","unstructured":"Law GR, Alnaji A, Alrefaii L, et al. Suboptimal nocturnal glucose control is associated with large for gestational age in treated gestational diabetes mellitus. Diabetes Care. 2019;42(5):810\u20135.","journal-title":"Diabetes Care"}],"container-title":["Diabetes Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-025-01756-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13300-025-01756-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-025-01756-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T17:32:51Z","timestamp":1757179971000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13300-025-01756-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":49,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1756"],"URL":"https:\/\/doi.org\/10.1007\/s13300-025-01756-1","relation":{},"ISSN":["1869-6953","1869-6961"],"issn-type":[{"value":"1869-6953","type":"print"},{"value":"1869-6961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]},"assertion":[{"value":"20 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Evanthia Gouveri has attended conferences sponsored by Berlin-Chemie, Sanofi, AstraZeneca, Novo Nordisk, Lilly, Boehringer Ingelheim; received speaker honoraria by Boehringer-Ingelheim, Sanofi-Aventis and Menarini. Drakopanagiotakis Fotios has attended conferences sponsored by Boehringer Ingelheim. Theodoros Panou has nothing to disclose. Paschalis Steiropoulos has been an advisory board member, has received honoraria as a speaker and has attended conferences sponsored by Astra-Zeneca, Boehringer Ingelheim, Chiesi, GSK, Elpen, Guidotti, Menarini, ResMed Specialty Therapeutics and Vivisol. Dimitrios Papazoglou declares associations: with Menarini, Novo Nordisk, Astra-Zeneca, Boehringer Ingelheim and Sanofi-Aventis. Nikolaos Papanas has been an advisory board member of Astra-Zeneca, Bayer, Boehringer Ingelheim, Menarini, MSD, Novo Nordisk, Pfizer, Takeda and TrigoCare International; has participated in sponsored studies by Astra-Zeneca, Eli-Lilly, GSK, MSD, Novo Nordisk, Novartis and Sanofi-Aventis; has received honoraria as a speaker for Astra-Zeneca, Bayer, Boehringer Ingelheim, Eli-Lilly, Elpen, Menarini, MSD, Mylan, Novo Nordisk, Pfizer, Sanofi-Aventis and Vianex; and has attended conferences sponsored by TrigoCare International, Eli-Lilly, Bayer, Galenica, Novo Nordisk, Pfizer and Sanofi-Aventis. Nikolaos Papanas is an Editorial Board member of Diabetes Therapy. Nikolaos Papanas was not involved in the selection of peer reviewers for the manuscript or any of the subsequent editorial decisions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}